|
| |
Articles
1-231 out of 231 article(s)
| Title |
Author |
Type |
Date |
Words |
| Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease. |
|
|
May 1, 2013 |
824 |
| Schizophrenia and Its Treatment Reviewed by NeuroPerspective. |
|
|
Mar 19, 2013 |
518 |
| Reviva Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder. |
|
|
Jan 14, 2013 |
837 |
| BioLineRx to Announce Interim Results of Phase II/III Trial for Schizophrenia Drug During Week of March 18, 2013. |
|
|
Jan 7, 2013 |
1207 |
| Alkermes Expands CNS Pipeline and Announces Positive Results from Phase 1 Study of ALKS 3831, a Novel Antipsychotic Therapy for the Treatment of Schizophrenia. |
|
|
Jan 3, 2013 |
1317 |
| Vanda Receives Negative Opinion from CHMP on Fanaptum(TM) for the Treatment of Schizophrenia. |
|
|
Dec 13, 2012 |
883 |
| Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder. |
|
Clinical report |
Nov 28, 2012 |
782 |
| DSPE Regulatory Update: Acceptance of the European Medicines Agency Submission for an Atypical Antipsychotic Agent Lurasidone. |
|
|
Oct 25, 2012 |
670 |
| DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. |
|
|
Oct 25, 2012 |
937 |
| DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. |
|
|
Oct 25, 2012 |
950 |
| Research and Markets: Key Findings from Treatment Algorithms: Schizophrenia. |
|
|
Oct 5, 2012 |
290 |
| United States : FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in INVEGA SUSTENNA Updated Product Label. |
|
|
Sep 28, 2012 |
363 |
| BioLineRx Announces Publication of EAGLE Study Results Demonstrating BL-1020's Efficacy in Improving Cognitive Function in Schizophrenia Patients. |
|
Clinical report |
Sep 27, 2012 |
1204 |
| Psychology. |
|
Author abstract |
Sep 22, 2012 |
2658 |
| Antipsychotic drug therapy: proceed with caution. |
Casey, Georgina |
|
Sep 1, 2012 |
4584 |
| Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results. |
|
Clinical report |
Aug 29, 2012 |
599 |
| New drug target for schizophrenia identified. |
|
|
Aug 14, 2012 |
461 |
| Antipsychotics need to pile up: new insights explain delayed action in schizophrenia drugs. |
Sanders, Laura |
|
Jul 14, 2012 |
445 |
| Research and Markets: Pharmacological and Psychosocial Treatments in Schizophrenia. |
|
|
Jun 20, 2012 |
429 |
| Depot antipsychotics boost compliance. |
Zoler, Mitchel L. |
|
Jun 1, 2012 |
980 |
| A placebo-controlled trial of bupropion for improving the positive and negative symptoms of schizophrenia. |
Rezaee, Omid; Masafi M, Saeede; Mohamadrez; Farshad, Akbarpour |
Report |
Jun 1, 2012 |
2741 |
| Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment of Newly Diagnosed Schizophrenia Patients. |
|
|
May 9, 2012 |
506 |
| Latuda[R] (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia. |
|
|
May 5, 2012 |
2437 |
| TMS guided by fMRI not effective for hallucinations. |
Boschert, Sherry |
Clinical report |
Apr 1, 2012 |
464 |
| Mylan Launches Generic Version of Seroquel[R] Tablets, 25 mg. |
|
|
Mar 28, 2012 |
413 |
| Reviva Pharmaceuticals Announces Enrollment of Patients in Phase 2 Clinical Study of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder. |
|
Clinical report |
Mar 12, 2012 |
933 |
| Cheap acne antibiotic could help ease schizophrenia symptoms. |
|
|
Mar 3, 2012 |
392 |
| Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia. |
|
|
Feb 28, 2012 |
1435 |
| 'Chemical cosh' drug doubles death risk in dementia patients. |
|
|
Feb 24, 2012 |
342 |
| How antipsychotic medications lead to obesity and diabetes. |
|
|
Feb 2, 2012 |
546 |
| FDA panel recommends loxapine for approval: from a meeting of the FDA's Psychopharmacologic Drugs Advisory Committee. |
Mechcatie, Elizabeth |
|
Jan 1, 2012 |
1047 |
| Best practices in: the treatment of adults with schizophrenia: managing schizophrenia and overall health. |
Mattingly, Gregory W. |
|
Jan 1, 2012 |
1793 |
| Alkermes Initiates Phase 3 Clinical Study of ALKS 9070 for Treatment of Schizophrenia. |
|
|
Dec 19, 2011 |
1161 |
| New Drug Application for Otsuka's Once-Monthly Aripiprazole Depot Formulation for Maintenance Treatment of Adult Patients with Schizophrenia Accepted for Review by the U.S. Food and Drug Administration. |
|
|
Nov 22, 2011 |
990 |
| Research and Markets: Global Schizophrenia Drug Pipeline Capsule - 2011. |
|
|
Sep 29, 2011 |
402 |
| Monday, 26 September 2011 THEPROFESSIONALS; Ensuring that patients get right prescription for anti-psychotic drugs Dr Jane Harrison explains how the latest phase of 1,000 Lives Plus work on the appropriate use of anti-psychotic drugs will benefit patients. |
|
|
Sep 26, 2011 |
615 |
| Groups back forcing meds. |
Correa, Frances |
Brief article |
Sep 1, 2011 |
158 |
| When Compared to Other Atypical Antipsychotics, Fewer Schizophrenia Patients Who Take Zyprexa in the First Line Progress to a Second-Line Therapy within a Year. |
|
|
Jul 27, 2011 |
511 |
| Cancer drugs may help treat schizophrenia. |
|
|
Jul 21, 2011 |
244 |
| Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia. |
|
|
Jun 30, 2011 |
948 |
| Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia. |
Garg, Rohit; Chavan, B.S.; Arun, Priti |
Report |
Jun 1, 2011 |
2292 |
| Psychosocial treatments backed for schizophrenia. |
Jancin, Bruce |
|
May 1, 2011 |
883 |
| INTELLIPHARMACEUTICS FILES ANDA FOR GENERIC SEROQUEL XR. |
|
|
Apr 27, 2011 |
307 |
| INVEGA Approved as Treatment for Schizophrenia in Adolescents. |
|
|
Apr 11, 2011 |
2320 |
| Risperdal(R) Consta(R) Associated With Lower Risk of Hospitalisation Compared to Treatment With Other Antipsychotics in Patients With Schizophrenia. |
|
Clinical report |
Mar 25, 2011 |
1584 |
| New study could lead to potential drug targets for schizophrenia, Parkinson's. |
|
|
Mar 13, 2011 |
429 |
| European Commission Approves XEPLION(R) for Treatment of Schizophrenia. |
|
|
Mar 9, 2011 |
1917 |
| Cognition unaffected by single schizophrenia Tx. |
Tucker, Miriam E. |
|
Mar 1, 2011 |
929 |
| The intersexual differences of sexual functions and prolactine levels in schizophrenia patients under antipsychotic medication/Antipsikotik tedavi uygulanan sizofreni hastalarinda prolaktin duzeyleri ve cinsel islevlerin cinsiyetlere gore karsilastirilmasi. |
Dogu, Basri; Kocabiyik, Ahmet; Karson, Fahri; Citak, Serhat; Incesu, Cem |
Report |
Mar 1, 2011 |
2929 |
| Antipsychotics for schizophrenia linked to subtle loss in brain volume. |
|
|
Feb 8, 2011 |
294 |
| Once-Daily Latuda[R] (lurasidone HCl) Now Available in Pharmacies Nationwide for the Treatment of Patients with Schizophrenia. |
|
|
Feb 3, 2011 |
2224 |
| Latuda[R] (lurasidone HCl) Significantly Improves Symptoms of Schizophrenia in Fifth Positive Placebo-Controlled Study. |
|
|
Dec 8, 2010 |
2967 |
| Phase II Study with First-in-Class Investigational Drug Demonstrates Improvement in Negative Symptoms in Patients with Schizophrenia. |
|
|
Dec 6, 2010 |
1338 |
| Pimozide augmentation therapy in treatment-resistant schizophrenia patients with poor or partial response to clozapine: a retrospective study/Klozapin tedavisine yeterli yanit alinamayan tedaviye direncli sizofreni hastalarinda pimozidle guclendirme yaklasimi: geriye donuk bir degerlendirme calismasi. |
Kisa, Cebrail; Akdag, Hatice Alkan; Aydemir, Cigdem; Goka, Erol |
Report |
Dec 1, 2010 |
3825 |
| FDA Approves Latuda to Treat Schizophrenia in Adults. |
|
|
Oct 28, 2010 |
503 |
| FDA Approves Once-Daily LATUDA[R] (lurasidone HCL) for the Treatment of Patients with Schizophrenia. |
|
|
Oct 28, 2010 |
2200 |
| Over the Next Three Years, Abilify and Seroquel XR Will Be the Fastest-Growing Drugs by Prescriptions for the Treatment of Major Depression. |
|
|
Oct 21, 2010 |
741 |
| Dopamine model could aid treatment of schizophrenia, drug addiction. |
|
|
Oct 21, 2010 |
278 |
| Otsuka Announces Phase 3 Aripiprazole Intramuscular (IM) Depot Trial Interim Analysis Reveals Efficacy Criteria Met. |
|
|
Oct 5, 2010 |
1884 |
| New brain research could lead to schizophrenia treatment. |
|
|
Oct 1, 2010 |
225 |
| Study finds frequent switching of antipsychotics. |
Helwick, Caroline |
|
Oct 1, 2010 |
557 |
| AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder. |
|
|
Sep 28, 2010 |
970 |
| Drugs to treat nausea, vomiting 'up clots risk'. |
|
|
Sep 22, 2010 |
402 |
| The quest for the correct dose: recent efforts shed light on antipsychotic dosing, but find much work is left to be done. |
Glazer, William M. |
|
Sep 1, 2010 |
1279 |
| After Peaking at $6.3 Billion in 2011, Generic Erosion of Atypical Antipsychotics Will Cause the Schizophrenia Drug Market to Decline to $5.2 Billion in 2019. |
|
|
Aug 5, 2010 |
700 |
| Committee for Medicinal Products for Human Use (CHMP) Issues Opinion on European Regulatory Filing for Merck's Atypical Antipsychotic Medication SYCREST[R] (asenapine). |
|
|
Jun 25, 2010 |
12118 |
| Schizophrenia drug 'shrinks brain'. |
|
|
Jun 8, 2010 |
269 |
| Schizophrenia drugs turn up volume of brain's key signaling system. |
|
|
May 15, 2010 |
257 |
| New Study Finds Off-Label Use of Atypical Antipsychotics Increases Risk of Diabetes Among the Elderly. |
|
|
May 13, 2010 |
998 |
| Early disruption of schizophrenia gene causes problems later. |
Sanders, Laura |
Brief article |
Mar 13, 2010 |
265 |
| Antipsychotic polypharmacy in schizophrenic inpatients/Yatan sizofreni hastalarinda coklu antipsikotik kullanimi. |
Ozalmete, Ozlem Albayrak; Ceylan, Mehmet Emin; Ozalmete, Onur; Sevim, Meltem Efe |
Report |
Mar 1, 2010 |
4176 |
| Augmentation of clozapine with pimozide: a case of a treatment-resistant schizophrenic patient/Klozapin tedavisini pimozid ile guclendirme yaklasimi: tedaviye direncli bir sizofreni olgusu. |
Akdag, Hatice Alkan; Kisa, Cebrail; Bekki, Gulcan; Goka, Erol |
Report |
Mar 1, 2010 |
2689 |
| Emerging Oral Atypical Antipsychotics Will Garner Only Limited Uptake in the Schizophrenia Drug Market. |
|
|
Feb 23, 2010 |
643 |
| Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders. |
|
|
Feb 4, 2010 |
917 |
| New biosensors show how drugs used to treat schizophrenia work. |
|
|
Dec 14, 2009 |
276 |
| Aripiprazole approved for autism-related irritability. |
Mechcatie, Elizabeth |
|
Dec 1, 2009 |
454 |
| Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia. |
|
|
Oct 28, 2009 |
1490 |
| Epilepsy drug could raise schizophrenia risk. |
|
|
Oct 22, 2009 |
242 |
| The outcome of behavioral intervention with a person living with schizophrenia who exhibited medication noncompliance: a case study. |
Kanahara, Shunsuke |
Case study |
Sep 22, 2009 |
3962 |
| Injectable beats oral antipsychotics for bipolar. |
McNamara, Damian |
Clinical report |
Sep 1, 2009 |
593 |
| Sublingual antipsychotic gets nod from FDA panel: asenapine safe, effective. |
Mechcatie, Elizabeth |
|
Aug 1, 2009 |
661 |
| Study: Clozapine may have saved schizophrenics. |
|
|
Jul 28, 2009 |
480 |
| Clozapine's risks may be offset by reduced suicides. |
|
|
Jul 14, 2009 |
467 |
| Schizophrenia drug may help fight cancer. |
|
|
Jun 3, 2009 |
175 |
| 'Singing brains' offer hope for better epilepsy, schizophrenia treatments. |
|
|
May 20, 2009 |
380 |
| Titan Announces FDA Approval of Fanapt[TM] (Iloperidone) For the Treatment of Schizophrenia. |
|
|
May 7, 2009 |
359 |
| FDA panel partly backs wider use of Seroquel. |
|
|
Apr 21, 2009 |
409 |
| Schizophrenia drug may lead to sudden cardiac death. |
|
Brief article |
Apr 21, 2009 |
253 |
| ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs. |
|
|
Mar 25, 2009 |
1033 |
| Prevalence of metabolic syndrome, characteristics of metabolic syndrome and relationship with the antipsychotics used in schizophrenia/Sizofrenide metabolik sendrom sikligi, metabolik sendromun ozellikleri ve kullanilan antipsikotiklerle iliskisi. |
Kaya, Mehmet Cemal; Virit, Osman; Altindag, Abdurrahman; Selek, Salih; Bulbul, Feridun; Bulut, Mahmu |
Clinical report |
Mar 1, 2009 |
4488 |
| Drugs raise death rate for dementia patients. |
|
Clinical report |
Jan 9, 2009 |
444 |
| WORLD TODAY: Alzheimer's drugs risk. |
|
|
Jan 9, 2009 |
98 |
| FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment. |
|
|
Oct 9, 2008 |
1608 |
| Off-label Medicine Combinations are Predominant Treatment of Schizophrenics According to PLoS Article. |
|
|
Sep 23, 2008 |
372 |
| Ginkgo biloba and treatment resistant schizophrenia. |
Finney-Brown, Tessa |
|
Sep 22, 2008 |
488 |
| Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia. |
|
|
Sep 15, 2008 |
113 |
| LILLY (ELI) & COMPANY - Olanzapine Maintains Treatment Benefit in Schizophrenia. |
|
|
Sep 2, 2008 |
2354 |
| Among women with schizophrenia who are being treated with antipsychotic medications, an estrogen patch can markedly improve their symptoms, results of a clinical trial show. |
|
Brief article |
Aug 11, 2008 |
285 |
| BioLineRx Initiates Phase 2b Clinical Trials of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
Jun 12, 2008 |
1109 |
| FDA adds new indications for aripiprazole. |
Osborne, Randall |
|
Jun 1, 2008 |
187 |
| New atypical shows efficacy for inpatients in early trial. |
Henderson, Gina L. |
|
Jun 1, 2008 |
413 |
| ABILIFY(R) (aripiprazole) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia. |
|
|
May 8, 2008 |
2196 |
| MedImpact Study Highlights the Effects of Restricted Access on Use of Antipsychotic Drugs. |
|
Report |
Apr 29, 2008 |
496 |
| ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia. |
|
|
Apr 22, 2008 |
1063 |
| Antipsychotic drugs are doing harm. |
|
|
Mar 16, 2008 |
788 |
| Getting the NAC of a novel schizophrenia Tx. |
Jancin, Bruce |
|
Mar 1, 2008 |
725 |
| FDA panel backs longer-lasting Zyprexa. |
|
Brief article |
Feb 12, 2008 |
259 |
| BioLineRx Announces Positive Results From Phase 2a Trial of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
Feb 4, 2008 |
1299 |
| ABILIFY approved for adolescent patients with schizophrenia. |
|
|
Dec 1, 2007 |
145 |
| OREXIGEN(TM) Therapeutics to Present Data Supporting Novel, PreClinical Drug Combination for Schizophrenia. |
|
|
Nov 1, 2007 |
242 |
| Elan Announces the Johnson & Johnson Pharmaceutical Research & Development Submission of a New Drug Application to the FDA for Paliperidone Palmitate Using Elan's Proprietary NanoCrystal(R) Technology. |
|
|
Oct 29, 2007 |
720 |
| New Survey Conveys Fundamental Shift in the Perceptions of Treatment Outcomes in Schizophrenia. |
|
|
Oct 9, 2007 |
1028 |
| Lilly adds strong warning label to Zyprexa. |
|
|
Oct 8, 2007 |
635 |
| Risperdal approved in teens for schizophrenia and BPD. |
Wachter, Kerri |
|
Sep 15, 2007 |
583 |
| Wyeth drops after court ruling on protonix. |
|
Brief article |
Sep 10, 2007 |
220 |
| Indications for risperidone expanded to teens, kids. |
Wachter, Kerri |
|
Sep 1, 2007 |
583 |
| AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended-Release Tablets Approved in Netherlands for the Acute and Long Term Treatment of Schizophrenia. |
|
|
Aug 29, 2007 |
617 |
| FDA seeks further testing of Wyeth depression drug, deems drug for schizophrenia not approvable. |
|
|
Aug 13, 2007 |
688 |
| CATIE results show overlap of schizophrenia, metabolic disorder. |
Kirn, Timothy F. |
|
Aug 1, 2007 |
435 |
| BioLineRx Initiates Phase II Trial of BL-1020, a First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
Jul 25, 2007 |
737 |
| BioLineRx Initiates a Clinical Receptor-Occupancy Study of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. |
|
|
May 16, 2007 |
643 |
| Antidepressants may benefit prepsychotic teens. |
Splete, Heidi |
|
May 1, 2007 |
330 |
| The depot paradox: long-acting formulations of antipsychotics can boost treatment adherence rates, but clinicians have been hesitant to use them. |
Glazer, William M. |
|
May 1, 2007 |
2199 |
| INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia. |
|
|
Apr 27, 2007 |
688 |
| The importance of early treatment of schizophrenia. |
|
|
Apr 1, 2007 |
2508 |
| ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research. |
|
|
Mar 29, 2007 |
1089 |
| Weitz & Luxenberg Responds to Study on Off-Label Use of Antipsychotics. |
|
|
Feb 6, 2007 |
488 |
| elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia. |
|
|
Feb 5, 2007 |
552 |
| Line of research could advance schizophrenia Tx. |
Goldman, Erik L. |
|
Feb 1, 2007 |
996 |
| Off-label use of atypicals. |
Schneider, Mary Ellen |
Brief article |
Feb 1, 2007 |
163 |
| Lilly reaches Zyprexa settlement. |
Schneider, Mary Ellen |
Brief article |
Feb 1, 2007 |
169 |
| FDA approves new drug for schizophrenia. |
|
|
Feb 1, 2007 |
141 |
| Omeros Receives up to $9 Million toward Development of Schizophrenia Treatment. |
|
|
Jan 10, 2007 |
470 |
| Johnson & Johnson (New Brunswick NJ) won approval for its once-a-day pill called Invega for treating schizophrenia. |
|
Brief article |
Jan 8, 2007 |
120 |
| FDA approves extended-release drug for schizophrenia. |
Walsh, Nancy |
|
Jan 1, 2007 |
386 |
| Schizophrenia, substance use need integrated Tx: take into account the possible synergistic effects between antipsychotics and drugs of abuse. |
Sherman, Carl |
|
Jan 1, 2007 |
1125 |
| Research and Markets: Market Research available on CNS Drug Discoveries 2006: Schizophrenia. |
|
|
Dec 15, 2006 |
559 |
| Improved monitoring of lipids, glucose needed. |
Walsh, Nancy |
|
Dec 1, 2006 |
431 |
| First agent for autism treats aggression, tantrums. |
McNamara, Damian |
Brief article |
Nov 15, 2006 |
264 |
| CUtLASS findings interesting but inconclusive. |
Sullivan, Michele G. |
Clinical report |
Nov 1, 2006 |
758 |
| HEALTH: Why the term schizophrenia only benefits the drug industry. |
|
|
Oct 10, 2006 |
178 |
| Data on clozapine augmentation are scarce but do exist. |
Finn, Robert |
|
Aug 1, 2006 |
777 |
| CATIE support of atypical antipsychotics debated. |
Kirn, Timothy F. |
Drug overview |
Jul 1, 2006 |
1209 |
| BioLineRx to Present BL-1020, First in Class Small Molecule for the Treatment of Schizophrenia, at the American Psychiatric Association Annual Meeting. |
|
|
May 18, 2006 |
436 |
| The Market for Typical or Atypical Antipsychotics for the Treatment of Schizophrenia Exceeded $5 Billion in 2005. |
|
|
May 18, 2006 |
515 |
| Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia. |
|
|
May 5, 2006 |
458 |
| Clozapine 'wins again' in phase II of CATIE. |
McNamara, Damian |
|
May 1, 2006 |
644 |
| BioLineRx Initiates Phase 1 Clinical Trials of BL-1020, First in Class Small Molecule for the Treatment Of Schizophrenia. |
|
|
Apr 10, 2006 |
515 |
| Placing the risk of diabetes in context: based on an interview with Leslie Citrome, MD, MPH. |
|
Interview |
Apr 1, 2006 |
3685 |
| The cognitive-behavioral treatment of schizophrenia: the state of the art and the evidence. |
Gaudiano, Brandon A. |
|
Mar 22, 2006 |
5535 |
| Olanzapine, haloperidol, and weight. |
Kirn, Timothy F. |
Brief article |
Mar 1, 2006 |
219 |
| Drug combination fails to benefit clozapine-refractory schizophrenia. |
Lowry, Fran |
|
Mar 1, 2006 |
315 |
| Policy making's unintended consequences: line-item management of schizophrenia treatment is not cost-effective. |
Oss, Monica E. |
|
Mar 1, 2006 |
623 |
| New Study Shows Equivalent Efficacy and Superior Tolerability of quetiapine Compared to risperidone in the Treatment of Schizophrenia. |
|
|
Jan 4, 2006 |
789 |
| Medication noncompliance high among Asians with schizophrenia. |
Brunk, Doug |
Brief article |
Jan 1, 2006 |
289 |
| Thinking on atypical dosages has changed: survey shows daily dosage of clozapine, risperdone down; trend is upward with olanzapine, quetiapine. |
Sherman, Carl |
|
Jan 1, 2006 |
727 |
| Tapering off medications even with recent-onset schizophrenia a bad idea. |
Melville, Nancy A. |
Statistical data |
Jan 1, 2006 |
495 |
| CATIE renews debate over old versus new antipsychotics: some experts warn against interpreting CATIE's findings as an endorsement of the typicals. |
Enos, Gary A. |
|
Jan 1, 2006 |
1313 |
| Necessity drives schizophrenia polypharmacy. |
Sherman, Carl |
|
Dec 1, 2005 |
955 |
| Schizophrenia prodrome therapies show promise: early intervention with antipsychotics and CBT appears to delay or prevent psychotic breaks. |
Mahoney, Diana |
|
Oct 1, 2005 |
1314 |
| Medication compliance vital in schizophrenia Tx. |
MacNeil, Jane Salodof |
|
Aug 1, 2005 |
635 |
| Cognitive side effects of anticholinergics. |
Leard-Hansson, Jan; Guttmacher, Laurence |
|
Aug 1, 2005 |
794 |
| Antipsychotics' effects differ in substance abusers: activation of cytochrome P-450 system by cigarette smoke appears to play a role in drug metabolism. |
McNamara, Damian |
|
Jun 1, 2005 |
533 |
| Dear healthcare professional. |
Lechleiter, John |
|
May 1, 2005 |
424 |
| Important safety information for Zyprexa. |
|
|
May 1, 2005 |
360 |
| Risperidone augmentation of clozapine works! Risperidone augmentation of clozapine doesn't work! A tale of two protocols. |
Citrome, Leslie |
|
May 1, 2005 |
1632 |
| Dear healthcare professional. |
Lechleiter, John |
|
Apr 1, 2005 |
424 |
| Important safety information for Zyprexa. |
|
|
Apr 1, 2005 |
338 |
| Newer antipsychotics, hyperlipidemia. |
Foley, Kevin |
Brief Article |
Mar 1, 2005 |
167 |
| SSRIs for negative symptoms of schizophrenia. |
Leard-Hansson, Jan; Guttmacher, Laurence |
|
Feb 1, 2005 |
771 |
| Clozapine calms aggression. |
Splete, Heidi |
Brief Article |
Feb 1, 2005 |
132 |
| Perspective. |
Bell, Carl C. |
|
Feb 1, 2005 |
352 |
| Anticonvulsants in psychiatry: their similarities are different Part 2--clinical applications. |
Grady, Meghan M. |
|
Feb 1, 2005 |
855 |
| Reducing violence in schizophrenia. |
Foley, Kevin |
Brief Article |
Jan 1, 2005 |
182 |
| Amisulpride's real-world benefit shown in schizophrenia. |
Sullivan, Michele G. |
|
Jan 1, 2005 |
317 |
| Choose atypicals for early onset schizophrenia: two drawbacks are the need for slow titration with younger patients and the high cost of newer agents. |
Walsh, Nancy |
|
Jan 1, 2005 |
908 |
| Online schizophrenia algorithm almost ready: international effort took 3 years to finish. |
Sullivan, Michele G. |
|
Nov 1, 2004 |
538 |
| High-dose ziprasidone effective for treatment-resistant schizophrenia. |
Finn, Robert |
|
Nov 1, 2004 |
437 |
| Reducing clozapine's metabolic side effects. |
Leard-Hansson, Jan; Guttmacher, Laurence |
|
Nov 1, 2004 |
798 |
| Compliance tougher in schizophrenia. |
McNamara, Damian |
|
Sep 1, 2004 |
692 |
| Depot atypical antipsychotic maintains remission in some. |
Sherman, Carl |
|
Jul 1, 2004 |
474 |
| Amisulpride vs. olanzapine. |
Evans, Jeff |
Brief Article |
Jul 1, 2004 |
132 |
| Risperidone soothes teens' externalizing behavior: compared with olanzapine. |
McNamara, Damian |
|
Nov 1, 2003 |
381 |
| Side effects guide antipsychotic drug choices: atypicals vs. typicals. |
Boschert, Sherry |
|
Oct 1, 2003 |
1034 |
| Glutaminergics promising for cognitive, negative symptoms: amino acids for schizophrenia. |
Sherman, Carl |
|
Oct 1, 2003 |
473 |
| Use caution when adding Rx to atypicals: augmenting psychotropics ill advised. (another antipsychotic drug). |
Sherman, Carl |
|
Oct 1, 2003 |
542 |
| Antipsychotic weight gain. |
Evans, Jeff |
Brief Article |
Oct 1, 2003 |
131 |
| Ziprasidone mesylate (Geodon for injection): the first injectable atypical antipsychotic medication. |
Sheehan, Valerie |
Clinical report |
Oct 1, 2003 |
4390 |
| Genetic variation can cloud schizophrenia Tx: African american patients. (treatment). |
Zoler, Mitchel L. |
|
Sep 1, 2003 |
548 |
| Alzheimer's drugs may boost schizophrenia therapy: rivastigmine, galantamine studied. |
Boschert, Sherry |
|
Aug 1, 2003 |
462 |
| Novel antipsychotic's side effect profile offers benefits. (Neurotransmitter Systems Stabilized). |
Sherman, Carl |
|
May 1, 2003 |
539 |
| Aripiprazole benefits are sustained over time. (Superior Side Effect Profile). |
Sherman, Carl |
Product/Service Evaluation |
May 1, 2003 |
558 |
| Supratherapeutic dosing of olanzapine may help refractory schizophrenia. (Improved Social Functioning). |
Jancin, Bruce |
|
May 1, 2003 |
602 |
| Cognition can be improved in schizophrenia. (Atypical Antipsychotics May Help). |
Jancin, Bruce |
|
May 1, 2003 |
583 |
| Clozaril. (New & Approved). |
Mechacatie, Elizabeth |
Brief Article |
Feb 15, 2003 |
343 |
| New & approved: elecsys proBNP immunoassay * aripiprazole. (Rx). |
Mechcatie, Elizabeth |
|
Jan 15, 2003 |
714 |
| Aripiprazole wins approval for schizophrenia. (Unique Properties Not Yet Proven). |
Mechcatie, Elizabeth |
|
Jan 1, 2003 |
558 |
| Studies support calming effect of Olanzapine. (More than 1,200 Patients). |
MacReady, Norra |
|
Jan 1, 2003 |
707 |
| Olanzapine risks confirmed. (Clinical Capsules). |
Evans, Jeff |
Brief Article |
Dec 1, 2002 |
172 |
| FDA approval likely for antipsychotic aripiprazole. (Different Mechanism of Action). |
Mechcatie, Elizabeth |
|
Oct 1, 2002 |
315 |
| Olanzapine benefits older patients. (Versus Risperidone). |
Evans, Jeff |
Brief Article |
Oct 1, 2002 |
171 |
| Ethnicity may affect antipsychotic Rx response. (South African Study). |
Mahoney, Diana |
|
Oct 1, 2002 |
670 |
| Study finds adjunctive divalproex benefits acute schizophrenia. (First Double-Blind Frial). |
Walsh, Nancy |
|
Sep 1, 2002 |
329 |
| Celecoxib for schizophrenia. (Clinical Capsules). |
Evans, Jeff |
Brief Article |
Jul 1, 2002 |
160 |
| First atypical comparison may individualize care. (Chronic Schizophrenia). |
Splete, Heidi |
Brief Article |
Apr 1, 2002 |
559 |
| Research on the drug treatment of schizophrenia: a critical appraisal and implications for social work education. |
Cohen, David (Dutch activist) |
|
Mar 22, 2002 |
10186 |
| Practical psychopharmacology. (Cognitive Impairment in Schizophrenia). |
Sherman, Carl |
Brief Article |
Feb 1, 2002 |
881 |
| Risperidone reduces relapse. (Clinical Capsules). |
Evans, Jeff |
Brief Article |
Feb 1, 2002 |
113 |
| Clozapine Reduces Hostility. (Clinical Capsules). |
Evans, Jeff |
Brief Article |
Jan 1, 2002 |
121 |
| Polypharmacy, Atypicals Top Pick For Schizophrenia. |
SHERMAN, CARL |
|
Sep 1, 2001 |
663 |
| Data Reanalysis Suggests Optimal Dose for Atypical Antipsychotics. |
SHERMAN, CARL |
|
Sep 1, 2001 |
373 |
| Integration of olanzapine determinations in a HPLC-diode array detection system for routine psychotropic drug monitoring. |
Llorca, Pierre M.; Coudore, Francois; Corpelet, Christophe; Buyens, Aurelie; Hoareau, Monique; Escha |
|
Sep 1, 2001 |
1509 |
| Intramuscular Olanzapine Alleviates Acute Agitation. |
IMPERIO, WINNIE ANNE |
|
Aug 1, 2001 |
575 |
| Atypical Improves Cognition in First Episode Psychosis. |
Walsh, Nancy |
|
Aug 1, 2001 |
228 |
| Off-Label Anticonvulsants Useful in Schizophrenia. |
SHERMAN, CARL |
|
Aug 1, 2001 |
645 |
| Antipsychotics Mean Higher Risk of MI, Arrhythmia for Some With Schizophrenia. |
Imperio, Winnie Anne |
|
Aug 1, 2001 |
256 |
| Ziprasidone Offers Long-Term Symptom Control. |
WALSH, NANCY |
|
Aug 1, 2001 |
422 |
| Once-Daily Antipsychotic Improves Schizophrenia. |
IMPERIO, WINNIE ANNE |
|
Jul 1, 2001 |
265 |
| Olanzapine May Worsen Insulin Resistance. |
Walsh, Nancy |
|
Jul 1, 2001 |
248 |
| Newer Antipsychotics Stabilize Schizophrenia Faster. |
WALSH, NANCY |
Brief Article |
Jul 1, 2001 |
240 |
| Novel Antipsychotics May Be Best for Schizophrenia. |
MANN, ARNOLD |
|
Jul 1, 2001 |
217 |
| Long-Acting Risperdal Improves Schizophrenia Symptoms. |
IMPERIO, WINNIE ANNE |
|
Jun 1, 2001 |
575 |
| The Role of Medications in the Employment of People with Schizophrenia. |
Meyer, Piper S. |
|
Oct 1, 1999 |
6701 |
| Schizophrenia: promising drug ... and infectious clues. |
|
|
Jun 18, 1994 |
540 |
| STUDY SHOWS USE OF BREAKTHROUGH DRUG REDUCES COSTLY HOSPITALIZATIONS |
|
Product/Service Evaluation |
Jun 22, 1993 |
733 |
| Schizophrenia - a national tragedy. |
|
|
Jan 1, 1993 |
611 |
| Price battle over schizophrenia drug. |
Bower, Bruce |
|
May 26, 1990 |
230 |
| Schizophrenia drug gains FDA approval. |
Bower, B. |
|
Oct 14, 1989 |
273 |
| Low-dose advantage for schizophrenics. |
Bower, Bruce |
|
Sep 24, 1988 |
604 |
| Low-dose caveat for schizophrenia. |
Bower, Bruce |
|
Jun 13, 1987 |
350 |
| Schizophrenia: new hope from an old drug. |
Bower, Bruce |
|
May 23, 1987 |
710 |
|
